PRESS RELEASE published on 06/21/2024 at 22:05, 3 months 14 days ago Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024 Description of the share repurchase program authorized by the Ordinary General Meeting of 20 June 2024 by Inventiva SA. Details on objectives, maximum capital proportion, and allocation of treasury shares presented Liquidity Agreement Ordinary General Meeting AMF General Regulations Share Repurchase Program Inventiva SA
BRIEF published on 06/21/2024 at 22:05, 3 months 14 days ago Results of the Combined Shareholders' General Meeting of June 20, 2024 Shareholders' Meeting Resolutions Votes Inventiva
PRESS RELEASE published on 06/21/2024 at 22:00, 3 months 14 days ago Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024 Inventiva announces voting results of Combined Shareholders' Meeting held on June 20, 2024. All resolutions, except 30th, were adopted. Details of votes and quorum provided Voting Results Quorum Combined Shareholders' Meeting Resolutions Adopted Inventiva
BRIEF published on 05/30/2024 at 08:35, 4 months 7 days ago Inventiva Combined General Meeting of June 20, 2024 - Conditions for making preparatory documents available Shareholders Biopharmaceutical General Assembly Preparatory Documents Inventive
BRIEF published on 05/30/2024 at 08:35, 4 months 7 days ago Inventiva: Status of voting rights and shares as of May 13, 2024 Euronext Paris Share Capital Voting Rights Financial Transparency Inventive
BRIEF published on 05/27/2024 at 09:12, 4 months 10 days ago Crossing threshold for INVENTIVA Capital Transfer Of Shares Crossing Threshold Inventiva UBS Group AG
BRIEF published on 05/21/2024 at 22:05, 4 months 15 days ago Inventiva Releases First Quarter 2024 Financial Results and Business Updates Financial Results Treasury BEI Inventive NATiV3 Clinical Trials
PRESS RELEASE published on 05/21/2024 at 22:00, 4 months 15 days ago Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update Inventiva reports 2024 First Quarter Financial Information and corporate update, including cash, deposits, and clinical trial progress. Company actively seeking financing options Financial Information Deposits Clinical Trial Cash Inventiva
Published on 10/05/2024 at 04:00, 1 day 5 hours ago Agents Amazed by Incredible New Benefits Announced at Epique Realty Livestream Event
Published on 10/05/2024 at 03:30, 1 day 5 hours ago Agents Excited by Transformative Company Announcements at Epique Realty Livestream Event
Published on 10/05/2024 at 00:05, 1 day 9 hours ago WOGC Enters Into Letter of Intent to Acquire Terra Metals Inc.
Published on 10/04/2024 at 20:45, 1 day 12 hours ago ONAR Appoints Sara Wetmore to Lead Corporate Communications and Marketing
Published on 10/04/2024 at 19:00, 1 day 14 hours ago Clear Start Tax's Proven Approach to Resolving Client's Tax Debt
Published on 10/04/2024 at 18:33, 1 day 14 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/04/2024 at 18:15, 1 day 15 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 10/04/2024 at 17:20, 1 day 16 hours ago The subscription price for exercise of warrants series TO5 has been determined to SEK 0.40
Published on 10/04/2024 at 16:55, 1 day 16 hours ago World Green Economy Summit 2024 Hosts a High-Level Ministerial Roundtable
Published on 10/04/2024 at 18:27, 1 day 15 hours ago Total number of voting rights and shares making up the share capital at September 30, 2024
Published on 10/04/2024 at 18:00, 1 day 15 hours ago Information concerning the total number of voting rights and shares in the share capital as of September 30, 2024
Published on 10/03/2024 at 17:45, 2 days 15 hours ago Aéroports de Paris SA - Voting rights as of 30 September 2024
Published on 10/03/2024 at 17:45, 2 days 15 hours ago CHARGEURS - Voting rights monthly statement as of September 30th, 2024
Published on 10/03/2024 at 17:42, 2 days 15 hours ago Mersen: Number of shares and voting rights as of September 30, 2024